lilly
Gates Foundation funds TB drug discovery
January 14, 2011Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis
Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …
Lilly and Boehringer sign major diabetes collaboration
January 12, 2011Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes
Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Patient deaths halt Lilly cancer trial
December 15, 2010Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam
Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
UK pharma faces rising costs from value-based pricing
December 3, 2010Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing
The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …
Lilly bolsters diagnostics presence with Avid acquisition
November 9, 2010Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly
Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …
Lilly to open diabetes research centre in China
November 2, 2010Research and Development China, Eli Lilly & Co, Lilly Research Laboratories in China, diabetes, lilly
The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …
Lilly suspends late-stage trials of diabetes drug Protege
October 22, 2010Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes
Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …
Alzheimer’s disease
October 16, 2010Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical
In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Lilly names new VP of communications
September 23, 2010Medical Communications appointment, lilly, medical communications
Jeffrey Winton will next month join Lilly as vice president of communications and take a place on the company’s global …
Transition drops new diabetes drug
September 20, 2010Research and Development Transition Therapeutics, diabetes, lilly
Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …
Digital Pharma: Lilly aims to be social on its Lillypad
September 16, 2010Medical Communications Digital Pharma blog, Twitter, blog, lilly
Lilly has jumped feet first into the social media scene this week, launching a corporate blog and a Twitter account. …
Lilly abandons late stage Alzheimer’s drug
August 17, 2010Research and Development Alzheimer's, lilly
Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
Lilly sponsors diabetic calendar for Ramadan
August 11, 2010Medical Communications Diabetes UK, disease awareness campaigns, lilly
UK Muslims with diabetes are being offered a special Ramadan calendar that features advice and tips about fasting during the …
Manufacturing news in brief
July 20, 2010Manufacturing and Production Apicore, Emergent, Merck & Co, PPS, Tianyin, lilly
A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
